"[P]erforming a preoperative assessment for the degree of central sensitization may allow gynecologic surgeons and patients to have a more informed discussion regarding the anticipated postoperative ...

Perioperative use of etoricoxib, a selective COX-2 inhibitor, in patients undergoing total abdominal hysterectomy significantly reduces both resting and elicited pain and opioid (morphine) consumption ...

During recovery from hysterectomy a person may experience pain, bleeding, and constipation. There may also be menopause-type symptoms, such as hot flashes. However, the side effects can depend on the ...

Regardless of how it is performed, hysterectomy is not significantly associated with de novo urinary incontinence overall or any of its subtypes. Hysterectomy is not an independent risk factor for de ...